This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEB9M0BY_M.jpg
The company’s financial woes were brought into sharp focus the day before, as it reported a third-quarter loss of $491.7 million, or $91.87 per share. This figure far exceeded both the expected loss of $17.64 per share and the previous year’s third-quarter loss of $112 million or $23.34 per share. Cano Health’s liquidity situation has also become increasingly precarious, with available cash dropping to $53 million from $101.5 million in August.
In an effort to stabilize its operations and finances, Cano Health has taken decisive action by appointing a new CEO and initiating workforce reductions. The company had initially entered the New York Stock Exchange with optimism following a merger with Barry Sternlicht’s Jaws Acquisition Corp in 2021. However, the current challenges are proving to be significant hurdles as it struggles to regain its footing amidst a rapidly declining stock price and shrinking cash reserves.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
